2016年4月23日至24日，作为复旦大学药学院成立80周年系列学术报告之一的第十四届“明日论坛”在上海大华锦绣假日酒店举行。本次活动由丹麦诺和诺德公司“青年科学人才发展计划”支持，来自全国各地的数十名年轻临床医师出席了两天的会议。在上海交通大学附属瑞金医院陈名道教授主持下，上海市第一人民院彭永德教授、北京大学第一医院李雪迎教授、美国《新英格兰医学杂志》照日格图教授、诺和诺德公司渠翊博士和祖宁博士围绕临床研究、实验统计、医学信息、文献检索和论文撰写等议题做了专题演讲。复旦大学药学院院长、国家新药筛选中心主任兼国家化合物样品库主任王明伟研究员应邀以“硫氧还蛋白相互作用蛋白抑制剂的药理作用—抗糖尿病原创新药研究之实践”为题作了精彩的报告，受到与会人员的热烈反响。诺和诺德（中国）制药有限公司张克洲副总裁和来自复旦大学药学院的近10名师生代表参加了本次活动。
The 14th "Tomorrow Forum" to commemorate the 80th anniversary of Fudan School of Pharmacy successfully held in Shanghai
As part of the seminar series to celebrate the 80th anniversary of School of Pharmacy, Fudan University, the 14th “Tomorrow Forum” sponsored by Novo Nordisk A/S of Denmark “Young Scientific Talent Development Program” (STEP) was held in Shanghai Jinxiu Holiday Inn Hotel between April 23 and April 24, 2016. Several dozen of young physicians from various parts of China attended the 2-day meeting. Chaired by Professor Mingdao Chen of Ruijin Hospital affiliated to Shanghai Jiaotong University, Drs. Yongde Peng (Shanghai First People’s Hospital), Xueying Li (The First Hospital affiliated to Peking University), Zhaori Getu (The New England Journal of Medicine, USA), Yi Qu (Novo Nordisk) and Ning Zu (Novo Nordisk) gave seminars covering topics such as clinical research, experimental statistics, medical information, literature study and paper preparation, etc. Professor Ming-Wei Wang, Dean, School of Pharmacy, Fudan University and Director of the National Center for Drug Screening/Chinese National Compound Library delivered an invited lecture entitled “Pharmacological studies on a small molecule inhibitor of thioredoxin-interacting protein – Practices of innovative research of anti-diabetic drugs” which was well applauded by the audience. Dr. Kezhou Zhang (Vice President) of Novo Nordisk (China) Pharmaceuticals, Inc. and 10 or so representatives from Fudan School of Pharmacy participated in the event.
